{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T19:36:12Z","timestamp":1793993772722,"version":"4.8.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2021\/41\/N\/NZ4\/03555"],"award-info":[{"award-number":["2021\/41\/N\/NZ4\/03555"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>Liver and lung metastases demonstrate distinct biological, particularly immunological, characteristics. We investigated whether preoperative complete blood count (CBC) parameters, which may reflect the immune system condition, predict early dissemination to the liver and lungs in colorectal cancer (CRC).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In this retrospective single-centre study, we included 268 resected CRC cases with complete 2-year follow-up and analysed preoperative CBC for association with early liver or lung metastasis development. Next, selected CBC and clinicopathological parameters were analysed with uni- and multivariable Cox regression. Independent factors affecting liver or lung metastasis-free survival were incorporated into composite scores, which were further evaluated with receiver operating characteristic (ROC) curves and dichotomised using a modified, specificity-focused, Youden approach to identify particularly high-risk patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Compared to metastasis-free patients, early liver metastases were related to decreases in red blood cells, haematocrit, lymphocytes and elevated monocyte-to-lymphocyte ratio, while lung metastases to lower eosinophil counts. A composite score of independent factors (erythrocytopenia, lower lymphocyte count and pN) yielded HR of 8.01 (95% CI 3.45\u201318.57, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) for liver-specific metastasis-free survival (MFS). For lung-specific MFS, the combination of eosinopenia, pN and primary tumour location showed HR of 13.69 (95% CI 4.34\u201343.20, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Early CRC metastases to the liver and lungs are associated with partially divergent clinicopathological and peripheral blood features. We propose simple, clinically implementable scores, based on routinely assessed parameters, to identify patients with an increased risk of early dissemination to the liver or lungs. After validation in independent cohorts, these scores may provide easily available prognostic information.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00384-024-04802-9","type":"journal-article","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T07:16:35Z","timestamp":1737443795000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Complete blood counts as potential risk factors of early dissemination to liver and lungs in resected colorectal cancer: a retrospective cohort study"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4596-4837","authenticated-orcid":false,"given":"Marta","family":"Pop\u0119da","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7628-6119","authenticated-orcid":false,"given":"Jolanta","family":"\u017bok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5648-345X","authenticated-orcid":false,"given":"Bart\u0142omiej","family":"Tomasik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9272-3462","authenticated-orcid":false,"given":"Renata","family":"Duchnowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9291-3928","authenticated-orcid":false,"given":"Micha\u0142","family":"Bie\u0144kowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,21]]},"reference":[{"issue":"3","key":"4802_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"4802_CR2","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1093\/annonc\/mdt591","volume":"25","author":"N Hugen","year":"2014","unstructured":"Hugen N, van de Velde CJH, de Wilt JHW, Nagtegaal ID (2014) Metastatic pattern in colorectal cancer is strongly influenced by histological subtype. Ann Oncol 25(3):651\u2013657","journal-title":"Ann Oncol"},{"issue":"4","key":"4802_CR3","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/bjs5.50299","volume":"4","author":"V V\u00e4yrynen","year":"2020","unstructured":"V\u00e4yrynen V, Wirta EV, Sepp\u00e4l\u00e4 T, Sihvo E, Mecklin JP, Vasala K et al (2020) Incidence and management of patients with colorectal cancer and synchronous and metachronous colorectal metastases: a population-based study. BJS Open 4(4):685\u2013692","journal-title":"BJS Open"},{"issue":"1","key":"4802_CR4","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1001\/jamaoncol.2023.5098","volume":"10","author":"J Nors","year":"2024","unstructured":"Nors J, Iversen LH, Erichsen R, Gotschalck KA, Andersen CL (2024) Incidence of recurrence and time to recurrence in stage I to III colorectal cancer: a nationwide Danish cohort study. JAMA Oncol 10(1):54\u201362","journal-title":"JAMA Oncol"},{"issue":"3","key":"4802_CR5","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1097\/SLA.0000000000002564","volume":"269","author":"NN Rahbari","year":"2019","unstructured":"Rahbari NN, Carr PR, Jansen L, Chang-Claude J, Weitz J, Hoffmeister M et al (2019) Time of metastasis and outcome in colorectal cancer. Ann Surg 269(3):494\u2013502","journal-title":"Ann Surg"},{"key":"4802_CR6","doi-asserted-by":"crossref","unstructured":"Ca\u00f1ellas-Socias A, Sancho E, Batlle E (2024) Mechanisms of metastatic colorectal cancer. Nat Rev Gastroenterol Hepatol","DOI":"10.1038\/s41575-024-00934-z"},{"key":"4802_CR7","unstructured":"NCCN (2024) Clinical Practice Guidelines in Oncology, colon cancer, Version 3"},{"key":"4802_CR8","unstructured":"NCCN (2024) Clinical Practice Guidelines in Oncology, rectal cancer, Version 2"},{"issue":"10","key":"4802_CR9","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.annonc.2020.06.022","volume":"31","author":"G Argil\u00e9s","year":"2020","unstructured":"Argil\u00e9s G, Tabernero J, Labianca R, Hochhauser D, Salazar R, Iveson T et al (2020) Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 31(10):1291\u20131305","journal-title":"Ann Oncol"},{"issue":"9","key":"4802_CR10","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.annonc.2021.06.015","volume":"32","author":"S Rao","year":"2021","unstructured":"Rao S, Guren MG, Khan K, Brown G, Renehan AG, Steigen SE et al (2021) Anal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up\u2606. Ann Oncol 32(9):1087\u20131100","journal-title":"Ann Oncol"},{"issue":"12","key":"4802_CR11","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1016\/S1470-2045(20)30527-1","volume":"21","author":"T Andr\u00e9","year":"2020","unstructured":"Andr\u00e9 T, Meyerhardt J, Iveson T, Sobrero A, Yoshino T, Souglakos I et al (2020) Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials. Lancet Oncol 21(12):1620\u20131629","journal-title":"Lancet Oncol"},{"issue":"3","key":"4802_CR12","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1001\/jamaoncol.2017.2899","volume":"4","author":"A Zaanan","year":"2018","unstructured":"Zaanan A, Shi Q, Taieb J, Alberts SR, Meyers JP, Smyrk TC et al (2018) Role of deficient DNA mismatch repair status in patients with stage III colon cancer treated with FOLFOX adjuvant chemotherapy: a pooled analysis from 2 randomized clinical trials. JAMA Oncol 4(3):379\u2013383","journal-title":"JAMA Oncol"},{"issue":"3","key":"4802_CR13","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.immuni.2016.02.025","volume":"44","author":"B Mlecnik","year":"2016","unstructured":"Mlecnik B, Bindea G, Angell HK, Maby P, Angelova M, Tougeron D et al (2016) Integrative analyses of colorectal cancer show Immunoscore is a stronger predictor of patient survival than microsatellite instability. Immunity 44(3):698\u2013711","journal-title":"Immunity"},{"issue":"18","key":"4802_CR14","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1200\/JCO.23.01648","volume":"42","author":"E Domingo","year":"2024","unstructured":"Domingo E, Kelly C, Hay J, Sansom O, Maka N, Oien K et al (2024) Prognostic and predictive value of Immunoscore in stage III colorectal cancer: pooled analysis of cases from the SCOT and IDEA-HORG studies. J Clin Oncol 42(18):2207\u20132218","journal-title":"J Clin Oncol"},{"issue":"24","key":"4802_CR15","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.1200\/JCO.2016.67.0414","volume":"34","author":"T Yamanaka","year":"2016","unstructured":"Yamanaka T, Oki E, Yamazaki K, Yamaguchi K, Muro K, Uetake H et al (2016) 12-gene recurrence score assay stratifies the recurrence risk in stage II\/III colon cancer with surgery alone: the SUNRISE study. J Clin Oncol 34(24):2906\u20132913","journal-title":"J Clin Oncol"},{"issue":"36","key":"4802_CR16","doi-asserted-by":"publisher","first-page":"4512","DOI":"10.1200\/JCO.2012.47.3116","volume":"31","author":"G Yothers","year":"2013","unstructured":"Yothers G, O\u2019Connell MJ, Lee M, Lopatin M, Clark-Langone KM, Millward C et al (2013) Validation of the 12-gene colon cancer recurrence score in NSABP C-07 as a predictor of recurrence in patients with stage II and III colon cancer treated with fluorouracil and leucovorin (FU\/LV) and FU\/LV plus oxaliplatin. J Clin Oncol 31(36):4512\u20134519","journal-title":"J Clin Oncol"},{"issue":"1","key":"4802_CR17","doi-asserted-by":"publisher","first-page":"12123","DOI":"10.1038\/s41598-020-69083-y","volume":"10","author":"SA Buechler","year":"2020","unstructured":"Buechler SA, Stephens MT, Hummon AB, Ludwig K, Cannon E, Carter TC et al (2020) ColoType: a forty gene signature for consensus molecular subtyping of colorectal cancer tumors using whole-genome assay or targeted RNA-sequencing. Sci Rep 10(1):12123","journal-title":"Sci Rep"},{"issue":"8","key":"4802_CR18","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1159\/000506369","volume":"98","author":"E Shinto","year":"2020","unstructured":"Shinto E, Oki E, Shimokawa M, Yamaguchi S, Ishiguro M, Morita M et al (2020) A validation study for recurrence risk stratification of stage II colon cancer using the 55-gene classifier. Oncology 98(8):534\u2013541","journal-title":"Oncology"},{"issue":"24","key":"4802_CR19","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1056\/NEJMoa2200075","volume":"386","author":"J Tie","year":"2022","unstructured":"Tie J, Cohen JD, Lahouel K, Lo SN, Wang Y, Kosmider S et al (2022) Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer. N Engl J Med 386(24):2261\u20132272","journal-title":"N Engl J Med"},{"issue":"17","key":"4802_CR20","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1182\/blood-2009-10-247296","volume":"115","author":"L Erpenbeck","year":"2010","unstructured":"Erpenbeck L, Sch\u00f6n MP (2010) Deadly allies: the fatal interplay between platelets and metastasizing cancer cells. Blood 115(17):3427\u20133436","journal-title":"Blood"},{"issue":"1","key":"4802_CR21","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1182\/blood-2016-01-636399","volume":"128","author":"R Leblanc","year":"2016","unstructured":"Leblanc R, Peyruchaud O (2016) Metastasis: new functional implications of platelets and megakaryocytes. Blood 128(1):24\u201331","journal-title":"Blood"},{"issue":"9","key":"4802_CR22","first-page":"4717","volume":"37","author":"D Gu","year":"2017","unstructured":"Gu D, Szallasi A (2017) Thrombocytosis portends adverse prognosis in colorectal cancer: a meta-analysis of 5,619 patients in 16 individual studies. Anticancer Res 37(9):4717\u20134726","journal-title":"Anticancer Res"},{"issue":"23","key":"4802_CR23","doi-asserted-by":"publisher","first-page":"e10831","DOI":"10.1097\/MD.0000000000010831","volume":"97","author":"XD Rao","year":"2018","unstructured":"Rao XD, Zhang H, Xu ZS, Cheng H, Shen W, Wang XP (2018) Poor prognostic role of the pretreatment platelet counts in colorectal cancer: a meta-analysis. Medicine (Baltimore) 97(23):e10831","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"4802_CR24","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s12957-021-02406-z","volume":"19","author":"X Huang","year":"2021","unstructured":"Huang X, Cui J, Li X, Liu C, Sun J, Yue J (2021) The decreased platelet-to-lymphocyte ratio could predict a good prognosis in patients with oligometastatic colorectal cancer: a single-center cohort retrospective study. World J Surg Oncol 19(1):297","journal-title":"World J Surg Oncol"},{"issue":"6","key":"4802_CR25","doi-asserted-by":"publisher","first-page":"931","DOI":"10.5858\/2008-132-931-MPOCRF","volume":"132","author":"G Disibio","year":"2008","unstructured":"Disibio G, French SW (2008) Metastatic patterns of cancers: results from a large autopsy study. Arch Pathol Lab Med 132(6):931\u2013939","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"4802_CR26","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/cam4.2673","volume":"9","author":"J Wang","year":"2020","unstructured":"Wang J, Li S, Liu Y, Zhang C, Li H, Lai B (2020) Metastatic patterns and survival outcomes in patients with stage IV colon cancer: a population-based analysis. Cancer Med 9(1):361\u2013373","journal-title":"Cancer Med"},{"issue":"3","key":"4802_CR27","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/path.1711500308","volume":"150","author":"L Weiss","year":"1986","unstructured":"Weiss L, Grundmann E, Torhorst J, Hartveit F, Moberg I, Eder M et al (1986) Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol 150(3):195\u2013203","journal-title":"J Pathol"},{"key":"4802_CR28","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jare.2023.08.011","volume":"61","author":"Y Gao","year":"2024","unstructured":"Gao Y, Chen S, Wang H, Wu C, An R, Li G et al (2024) Liver metastases across cancer types sharing tumor environment immunotolerance can impede immune response therapy and immune monitoring. J Adv Res 61:151\u2013164","journal-title":"J Adv Res"},{"issue":"1","key":"4802_CR29","doi-asserted-by":"publisher","first-page":"e000491","DOI":"10.1136\/jitc-2019-000491","volume":"8","author":"S Garc\u00eda-Mulero","year":"2020","unstructured":"Garc\u00eda-Mulero S, Alonso MH, Pardo J, Santos C, Sanjuan X, Salazar R et al (2020) Lung metastases share common immune features regardless of primary tumor origin. J Immunother Cancer 8(1):e000491","journal-title":"J Immunother Cancer"},{"issue":"1","key":"4802_CR30","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s13059-021-02363-6","volume":"22","author":"WJ Ho","year":"2021","unstructured":"Ho WJ, Erbe R, Danilova L, Phyo Z, Bigelow E, Stein-O\u2019Brien G et al (2021) Multi-omic profiling of lung and liver tumor microenvironments of metastatic pancreatic cancer reveals site-specific immune regulatory pathways. Genome Biol 22(1):154","journal-title":"Genome Biol"},{"issue":"13","key":"4802_CR31","doi-asserted-by":"publisher","first-page":"1030147","DOI":"10.3389\/fimmu.2022.1030147","volume":"17","author":"JW Conway","year":"2022","unstructured":"Conway JW, Braden J, Wilmott JS, Scolyer RA, Long GV, Da Silva PI (2022) The effect of organ-specific tumor microenvironments on response patterns to immunotherapy. Front Immunol 17(13):1030147","journal-title":"Front Immunol"},{"key":"4802_CR32","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2147\/CMAR.S441675","volume":"16","author":"Q Luo","year":"2024","unstructured":"Luo Q, Quan Y, Liu W, Wu Z, Qiu W, Liang W et al (2024) Seed and soil: consensus molecular subgroups (CMS) and tumor microenvironment features between primary lesions and metastases of different organ sites in colorectal cancer. Cancer Manag Res 16:225\u2013243","journal-title":"Cancer Manag Res"},{"issue":"12","key":"4802_CR33","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","volume":"12","author":"E von Elm","year":"2014","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP et al (2014) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg Lond Engl 12(12):1495\u20131499","journal-title":"Int J Surg Lond Engl"},{"key":"4802_CR34","unstructured":"R Core Team (2022) R: a language and environment for statistical computing [Internet]. Vienna, Austria: R Foundation for Statistical Computing. Available from: https:\/\/www.R-project.org\/"},{"key":"4802_CR35","doi-asserted-by":"crossref","unstructured":"Wickham H (2016) ggplot2: elegant graphics for data analysis [Internet]. Springer-Verlag New York. Available from: https:\/\/ggplot2.tidyverse.org","DOI":"10.1007\/978-3-319-24277-4_9"},{"key":"4802_CR36","unstructured":"Kassambara A, Kosinski M, Biecek P (2021) Survminer: drawing survival curves using \u2018ggplot2\u2019 [Internet]. Available from: https:\/\/CRAN.R-project.org\/package=survminer"},{"key":"4802_CR37","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC et al (2011) pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 12:77","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"4802_CR38","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1214\/19-AOAS1287","volume":"14","author":"W Wang","year":"2020","unstructured":"Wang W, Aseltine R, Chen K, Yan J (2020) Integrative survival analysis with uncertain event times in application to a suicide risk study. Ann Appl Stat 14(1):51\u201373","journal-title":"Ann Appl Stat"},{"issue":"3","key":"4802_CR39","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.ccell.2023.02.018","volume":"41","author":"L Patras","year":"2023","unstructured":"Patras L, Shaashua L, Matei I, Lyden D (2023) Immune determinants of the pre-metastatic niche. Cancer Cell 41(3):546\u2013572","journal-title":"Cancer Cell"},{"issue":"5","key":"4802_CR40","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1093\/jamia\/ocv195","volume":"23","author":"Y Kinar","year":"2016","unstructured":"Kinar Y, Kalkstein N, Akiva P, Levin B, Half EE, Goldshtein I et al (2016) Development and validation of a predictive model for detection of colorectal cancer in primary care by analysis of complete blood counts: a binational retrospective study. J Am Med Inform Assoc JAMIA 23(5):879\u2013890","journal-title":"J Am Med Inform Assoc JAMIA"},{"issue":"2","key":"4802_CR41","doi-asserted-by":"publisher","first-page":"e0171759","DOI":"10.1371\/journal.pone.0171759","volume":"12","author":"Y Kinar","year":"2017","unstructured":"Kinar Y, Akiva P, Choman E, Kariv R, Shalev V, Levin B et al (2017) Performance analysis of a machine learning flagging system used to identify a group of individuals at a high risk for colorectal cancer. PLoS ONE 12(2):e0171759","journal-title":"PLoS ONE"},{"issue":"120 Suppl 23","key":"4802_CR42","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.1002\/cncr.29049","volume":"1","author":"KA Cronin","year":"2014","unstructured":"Cronin KA, Ries LAG, Edwards BK (2014) The surveillance, epidemiology, and end results (SEER) program of the National Cancer Institute. Cancer 1(120 Suppl 23):3755\u20133757","journal-title":"Cancer"},{"issue":"1","key":"4802_CR43","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12957-022-02558-6","volume":"20","author":"M Hao","year":"2022","unstructured":"Hao M, Li H, Wang K, Liu Y, Liang X, Ding L (2022) Predicting metachronous liver metastasis in patients with colorectal cancer: development and assessment of a new nomogram. World J Surg Oncol 20(1):80","journal-title":"World J Surg Oncol"},{"issue":"12","key":"4802_CR44","doi-asserted-by":"publisher","first-page":"107107","DOI":"10.1016\/j.ejso.2023.107107","volume":"49","author":"W Zhang","year":"2023","unstructured":"Zhang W, Guan X, Jiao S, Wang G, Wang X (2023) Development and validation of an artificial intelligence prediction model and a survival risk stratification for lung metastasis in colorectal cancer from highly imbalanced data: a multicenter retrospective study. Eur J Surg Oncol 49(12):107107","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"4802_CR45","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s00384-019-03270-w","volume":"34","author":"Y Huang","year":"2019","unstructured":"Huang Y, Zhao M, Yin J, Lu T, Yang X, Yuan G et al (2019) Pulmonary metastasis in newly diagnosed colon-rectal cancer: a population-based nomogram study. Int J Colorectal Dis 34(5):867\u2013878","journal-title":"Int J Colorectal Dis"},{"key":"4802_CR46","doi-asserted-by":"publisher","first-page":"1183072","DOI":"10.3389\/fonc.2023.1183072","volume":"13","author":"B Qiu","year":"2023","unstructured":"Qiu B, Shen Z, Yang D, Wang Q (2023) Applying machine learning techniques to predict the risk of lung metastases from rectal cancer: a real-world retrospective study. Front Oncol 13:1183072","journal-title":"Front Oncol"},{"issue":"6","key":"4802_CR47","doi-asserted-by":"publisher","first-page":"108305","DOI":"10.1016\/j.ejso.2024.108305","volume":"50","author":"BW Nuijens","year":"2024","unstructured":"Nuijens BW, Lindeboom R, Van Den Broek JJ, Geenen RWF, Schreurs WH (2024) A prediction model for lung metastases in patients with indeterminate pulmonary nodules in newly diagnosed colorectal cancer. Eur J Surg Oncol 50(6):108305","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"4802_CR48","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/ctm2.20","volume":"10","author":"S Mo","year":"2020","unstructured":"Mo S, Cai X, Zhou Z, Li Y, Hu X, Ma X et al (2020) Nomograms for predicting specific distant metastatic sites and overall survival of colorectal cancer patients: a large population-based real-world study. Clin Transl Med 10(1):169\u2013181","journal-title":"Clin Transl Med"},{"issue":"1","key":"4802_CR49","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12957-021-02140-6","volume":"19","author":"T Luo","year":"2021","unstructured":"Luo T, Wang Y, Shan X, Bai Y, Huang C, Li G et al (2021) Nomogram based on homogeneous and heterogeneous associated factors for predicting distant metastases in patients with colorectal cancer. World J Surg Oncol 19(1):30","journal-title":"World J Surg Oncol"},{"issue":"7","key":"4802_CR50","doi-asserted-by":"publisher","first-page":"108362","DOI":"10.1016\/j.ejso.2024.108362","volume":"50","author":"Z Guo","year":"2024","unstructured":"Guo Z, Zhang Z, Liu L, Zhao Y, Liu Z, Zhang C et al (2024) Machine learning for predicting liver and\/or lung metastasis in colorectal cancer: a retrospective study based on the SEER database. Eur J Surg Oncol 50(7):108362","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"4802_CR51","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1093\/carcin\/bgad098","volume":"45","author":"X Li","year":"2024","unstructured":"Li X, Wu M, Wu M, Liu J, Song L, Wang J et al (2024) A radiomics and genomics-derived model for predicting metastasis and prognosis in colorectal cancer. Carcinogenesis 45(3):170\u2013180","journal-title":"Carcinogenesis"},{"key":"4802_CR52","doi-asserted-by":"publisher","first-page":"861892","DOI":"10.3389\/fonc.2022.861892","volume":"12","author":"Y Li","year":"2022","unstructured":"Li Y, Gong J, Shen X, Li M, Zhang H, Feng F et al (2022) Assessment of primary colorectal cancer CT radiomics to predict metachronous liver metastasis. Front Oncol 12:861892","journal-title":"Front Oncol"},{"issue":"14","key":"4802_CR53","doi-asserted-by":"publisher","first-page":"5155","DOI":"10.1002\/cam4.3185","volume":"9","author":"M Liu","year":"2020","unstructured":"Liu M, Ma X, Shen F, Xia Y, Jia Y, Lu J (2020) MRI-based radiomics nomogram to predict synchronous liver metastasis in primary rectal cancer patients. Cancer Med 9(14):5155\u20135163","journal-title":"Cancer Med"},{"issue":"23","key":"4802_CR54","doi-asserted-by":"publisher","first-page":"7209","DOI":"10.1158\/1078-0432.CCR-17-0306","volume":"23","author":"JG Joung","year":"2017","unstructured":"Joung JG, Oh BY, Hong HK, Al-Khalidi H, Al-Alem F, Lee HO et al (2017) Tumor heterogeneity predicts metastatic potential in colorectal cancer. Clin Cancer Res Off J Am Assoc Cancer Res 23(23):7209\u20137216","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"3","key":"4802_CR55","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/ng.3214","volume":"47","author":"A Sottoriva","year":"2015","unstructured":"Sottoriva A, Kang H, Ma Z, Graham TA, Salomon MP, Zhao J et al (2015) A Big Bang model of human colorectal tumor growth. Nat Genet 47(3):209\u2013216","journal-title":"Nat Genet"},{"issue":"1","key":"4802_CR56","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.1038\/s41598-019-39651-y","volume":"9","author":"Z Shu","year":"2019","unstructured":"Shu Z, Fang S, Ding Z, Mao D, Cai R, Chen Y et al (2019) MRI-based radiomics nomogram to detect primary rectal cancer with synchronous liver metastases. Sci Rep 9(1):3374","journal-title":"Sci Rep"},{"issue":"1","key":"4802_CR57","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00330-018-5539-3","volume":"29","author":"T Hu","year":"2019","unstructured":"Hu T, Wang S, Huang L, Wang J, Shi D, Li Y et al (2019) A clinical-radiomics nomogram for the preoperative prediction of lung metastasis in colorectal cancer patients with indeterminate pulmonary nodules. Eur Radiol 29(1):439\u2013449","journal-title":"Eur Radiol"},{"issue":"1","key":"4802_CR58","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1186\/s12967-023-04460-5","volume":"21","author":"K He","year":"2023","unstructured":"He K, Wang Z, Luo M, Li B, Ding N, Li L et al (2023) Metastasis organotropism in colorectal cancer: advancing toward innovative therapies. J Transl Med 21(1):612","journal-title":"J Transl Med"},{"issue":"5","key":"4802_CR59","doi-asserted-by":"publisher","first-page":"816","DOI":"10.3390\/jpm12050816","volume":"12","author":"A Alsalman","year":"2022","unstructured":"Alsalman A, Al-Mterin MA, Abu-Dayeh A, Alloush F, Murshed K, Elkord E (2022) Associations of complete blood count parameters with disease-free survival in right- and left-sided colorectal cancer patients. J Pers Med 12(5):816","journal-title":"J Pers Med"},{"issue":"4","key":"4802_CR60","doi-asserted-by":"publisher","first-page":"e23132","DOI":"10.1002\/jcla.23132","volume":"34","author":"D Guo","year":"2020","unstructured":"Guo D, Li X, Xie A, Cao Q, Zhang J, Zhang F et al (2020) Differences in oncological outcomes and inflammatory biomarkers between right-sided and left-sided stage I-III colorectal adenocarcinoma. J Clin Lab Anal 34(4):e23132","journal-title":"J Clin Lab Anal"},{"issue":"9","key":"4802_CR61","doi-asserted-by":"publisher","first-page":"843074","DOI":"10.3389\/fmed.2022.843074","volume":"20","author":"M Hernandez-Ainsa","year":"2022","unstructured":"Hernandez-Ainsa M, Velamazan R, Lanas A, Carrera-Lasfuentes P, Piazuelo E (2022) Blood-cell-based inflammatory markers as a useful tool for early diagnosis in colorectal cancer. Front Med 20(9):843074","journal-title":"Front Med"},{"issue":"20","key":"4802_CR62","doi-asserted-by":"publisher","first-page":"6540","DOI":"10.3390\/jcm12206540","volume":"12","author":"RJ Sala","year":"2023","unstructured":"Sala RJ, Ery J, Cuesta-Peredo D, Muedra V, Rodilla V (2023) Complete blood count alterations prior to the diagnosis of colorectal cancer may help in the detection of synchronous liver metastases. J Clin Med 12(20):6540","journal-title":"J Clin Med"},{"issue":"5","key":"4802_CR63","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.7150\/jca.29018","volume":"10","author":"Y Li","year":"2019","unstructured":"Li Y, Xing C, Wei M, Wu H, Hu X, Li S et al (2019) Combining red blood cell distribution width (RDW-CV) and CEA predict poor prognosis for survival outcomes in colorectal cancer. J Cancer 10(5):1162\u20131170","journal-title":"J Cancer"},{"issue":"4","key":"4802_CR64","doi-asserted-by":"publisher","first-page":"945","DOI":"10.3390\/cancers14040945","volume":"14","author":"KC Cheng","year":"2022","unstructured":"Cheng KC, Lin YM, Liu CC, Wu KL, Lee KC (2022) High red cell distribution width is associated with worse prognosis in early colorectal cancer after curative resection: a propensity-matched analysis. Cancers 14(4):945","journal-title":"Cancers"},{"issue":"12","key":"4802_CR65","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.3748\/wjg.v30.i12.1714","volume":"30","author":"D Peng","year":"2024","unstructured":"Peng D, Li ZW, Liu F, Liu XR, Wang CY (2024) Predictive value of red blood cell distribution width and hematocrit for short-term outcomes and prognosis in colorectal cancer patients undergoing radical surgery. World J Gastroenterol 30(12):1714\u20131726","journal-title":"World J Gastroenterol"},{"issue":"4","key":"4802_CR66","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.4240\/wjgs.v16.i4.1055","volume":"16","author":"DX Cheng","year":"2024","unstructured":"Cheng DX, Xu KD, Liu HB, Liu Y (2024) Prognostic value of a nomogram model for postoperative liver metastasis of colon cancer. World J Gastrointest Surg 16(4):1055\u20131065","journal-title":"World J Gastrointest Surg"},{"issue":"15","key":"4802_CR67","doi-asserted-by":"publisher","first-page":"8002","DOI":"10.3390\/ijms22158002","volume":"22","author":"T Yamamoto","year":"2021","unstructured":"Yamamoto T, Kawada K, Obama K (2021) Inflammation-related biomarkers for the prediction of prognosis in colorectal cancer patients. Int J Mol Sci 22(15):8002","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4802_CR68","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3390\/biology11030385","volume":"11","author":"C Gawi\u0144ski","year":"2024","unstructured":"Gawi\u0144ski C, Michalski W, Mr\u00f3z A, Wyrwicz L (2024) Correlation between lymphocyte-to-monocyte ratio (LMR), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and tumor-infiltrating lymphocytes (TILs) in left-sided colorectal cancer patients. Biology 11(3):385","journal-title":"Biology"},{"key":"4802_CR69","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2147\/JIR.S391932","volume":"16","author":"A Misiewicz","year":"2023","unstructured":"Misiewicz A, Dymicka-Piekarska V (2023) Fashionable, but what is their real clinical usefulness? NLR, LMR, and PLR as a promising indicator in colorectal cancer prognosis: a systematic review. J Inflamm Res 16:69\u201381","journal-title":"J Inflamm Res"},{"issue":"10","key":"4802_CR70","doi-asserted-by":"publisher","first-page":"1139503","DOI":"10.3389\/fsurg.2023.1139503","volume":"27","author":"G Guo","year":"2023","unstructured":"Guo G, Hu X, Gao T, Zhou H, Li B, Zhou C et al (2023) Potential impact of platelet-to-lymphocyte ratio on prognosis in patients with colorectal cancer: a systematic review and meta-analysis. Front Surg 27(10):1139503","journal-title":"Front Surg"},{"key":"4802_CR71","doi-asserted-by":"publisher","first-page":"106959","DOI":"10.1016\/j.ijsu.2022.106959","volume":"107","author":"N Lin","year":"2022","unstructured":"Lin N, Li J, Yao X, Zhang X, Liu G, Zhang Z et al (2022) Prognostic value of neutrophil-to-lymphocyte ratio in colorectal cancer liver metastasis: a meta-analysis of results from multivariate analysis. Int J Surg Lond Engl 107:106959","journal-title":"Int J Surg Lond Engl"},{"issue":"588","key":"4802_CR72","doi-asserted-by":"publisher","first-page":"216778","DOI":"10.1016\/j.canlet.2024.216778","volume":"28","author":"Q Chen","year":"2024","unstructured":"Chen Q, Deng Y, Li Y, Chen J, Zhang R, Yang L et al (2024) Association of preoperative aspartate aminotransferase to platelet ratio index with outcomes and tumour microenvironment among colorectal cancer with liver metastases. Cancer Lett 28(588):216778","journal-title":"Cancer Lett"},{"issue":"1","key":"4802_CR73","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00423-023-02786-8","volume":"408","author":"G Portale","year":"2023","unstructured":"Portale G, Bartolotta P, Azzolina D, Gregori D, Fiscon V (2023) Prognostic role of platelet-to-lymphocyte ratio, neutrophil-to-lymphocyte, and lymphocyte-to-monocyte ratio in operated rectal cancer patients: systematic review and meta-analysis. Langenbecks Arch Surg 408(1):85","journal-title":"Langenbecks Arch Surg"},{"issue":"37","key":"4802_CR74","doi-asserted-by":"publisher","first-page":"101556","DOI":"10.1016\/j.suronc.2021.101556","volume":"1","author":"HKS Hamid","year":"2021","unstructured":"Hamid HKS, Davis GN, Trejo-Avila M, Igwe PO, Garcia-Mar\u00edn A (2021) Prognostic and predictive value of neutrophil-to-lymphocyte ratio after curative rectal cancer resection: a systematic review and meta-analysis. Surg Oncol 1(37):101556","journal-title":"Surg Oncol"},{"issue":"1","key":"4802_CR75","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/ijc.34691","volume":"154","author":"AE Constantinescu","year":"2024","unstructured":"Constantinescu AE, Bull CJ, Jones N, Mitchell R, Burrows K, Dimou N et al (2024) Circulating white blood cell traits and colorectal cancer risk: a Mendelian randomisation study. Int J Cancer 154(1):94\u2013103","journal-title":"Int J Cancer"},{"issue":"5","key":"4802_CR76","doi-asserted-by":"publisher","first-page":"e243","DOI":"10.1111\/ajco.12871","volume":"14","author":"Y Wei","year":"2018","unstructured":"Wei Y, Zhang X, Wang G, Zhou Y, Luo M, Wang S et al (2018) The impacts of pretreatment circulating eosinophils and basophils on prognosis of stage I-II colorectal cancer. Asia Pac J Clin Oncol 14(5):e243\u2013e251","journal-title":"Asia Pac J Clin Oncol"},{"issue":"3","key":"4802_CR77","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1084\/jem.121.3.439","volume":"121","author":"P Gold","year":"1965","unstructured":"Gold P, Freedman SO (1965) Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J Exp Med 121(3):439\u2013462","journal-title":"J Exp Med"},{"issue":"4","key":"4802_CR78","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1081\/CNV-58878","volume":"23","author":"MJ Goldstein","year":"2005","unstructured":"Goldstein MJ, Mitchell EP (2005) Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer. Cancer Invest 23(4):338\u2013351","journal-title":"Cancer Invest"},{"key":"4802_CR79","doi-asserted-by":"publisher","first-page":"e2100535","DOI":"10.1200\/PO.21.00535","volume":"6","author":"H Bando","year":"2022","unstructured":"Bando H, Nakamura Y, Taniguchi H, Shiozawa M, Yasui H, Esaki T et al (2022) Effects of metastatic sites on circulating tumor DNA in patients with metastatic colorectal cancer. JCO Precis Oncol 6:e2100535","journal-title":"JCO Precis Oncol"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-024-04802-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00384-024-04802-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-024-04802-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T19:10:35Z","timestamp":1737486635000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00384-024-04802-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,21]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4802"],"URL":"https:\/\/doi.org\/10.1007\/s00384-024-04802-9","relation":{},"ISSN":["1432-1262"],"issn-type":[{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,21]]},"assertion":[{"value":"30 December 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Bioethical Committee of the Medical University of Gda\u0144sk (NKBBN\/688\/2022).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Marta Pop\u0119da, Jolanta \u017bok and Renata Duchnowska declare no financial conflict of interest. Bart\u0142omiej Tomasik received lecture fees from Pfizer and honoraria from Roche. Micha\u0142 Bie\u0144kowski received lecture fees from Pfizer. All authors have no non-financial interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}